Hematologia Geral

M-A | Plasma convalescente é seguro, mas não melhora os desfechos no tratamento da COVID-19.

7 Jul, 2021 | 08:07h

Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research – Transfusion Medicine

---

Trombocitopenia trombótica imune induzida por vacina (vaccine-induced immune thrombotic thrombocytopenia – VITT) – Uma nova entidade clinicopatológica com apresentações clínicas heterogêneas.

2 Jul, 2021 | 11:17h

Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations – British Journal of Haematology

Comentário: Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection – MedicalXpress

---

Embolia pulmonar em pacientes com COVID-19: incidência, fatores de risco, características clínicas e desfechos.

30 Jun, 2021 | 10:43h

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome – European Heart Journal

---

Preocupado com as últimas notícias sobra a AstraZeneca? Estes 3 gráficos ajudam a compreender o risco – “Na Austrália, 2 pessoas morreram de trombose com trombocitopenia após 3,8 milhões de doses da vacina da AstraZeneca terem sido aplicadas.”

21 Jun, 2021 | 10:58h

Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the risk – The Conversation

---

Revisão | Tromboembolismo venoso e arterial em pacientes com câncer.

16 Jun, 2021 | 10:49h

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

Resumo: Venous and Arterial Thromboembolism in Patients With Cancer – American College of Cardiology

---